128 results found.
            
ORTHOKNOW® - November 15, 2006
3Q06 IN REVIEW Rebound in large joint growth and merger speculation make for exciting quarter INSIDE THIS ISSUE: 3Q06 IN 1 REVIEW Rebound in large joint growth and merger speculation make for exciting quarter ONLINE EXTRA: To view growth for the largest companies in each segment from 2002 ...
BARE BONES® - October 15, 2006
AAP IMPLANTATE signed a letter of intent on a merger with FAME MEDICAL via a pure share transaction. Both companies focus on bone cements, bone graft substitutes, tissue processing and regeneration with complementary product ranges. For 2005, FAME posted revenues of € 7.6MM (US $9.7MM). (aap Im...
ORTHOKNOW® - August 15, 2006
STRATEGIC INSIGHTS INTO THE ORTHOPAEDIC INDUSTRY 2Q06 IN REVIEW Large Joints Slip, Taking Suppliers With Them Thanks to a former Smith & Nephew sales rep who tried to get his competitors to “collude” on price, we got to experience some excitement amid rather dull quarterly reports, at...
BARE BONES® - November 15, 2005
AAP IMPLANTATE is acquiring retroactively (from 7/1/05) all shares of OSARTIS, the manufacturer of Ostim® synthetic bone replacement. aap currently istributes Ostim in Germany and Austria and is negotiating with other potential distribution partners in Europe and Asia. aap will apply for FDA clea...
BARE BONES® - September 15, 2005
AAP IMPLANTATE signed a multi-year contract to become BIOMET DEUTSCHLANDs bone cement sales partner. The agreement may reportedly largely offset the 4/05 termination of a bone cement sales agreement between aap and SCHERING-PLOUGH. (See Bare Bones, 5/05.) (aap Implantate AG, 8/30/05)
BARE BONES® - June 15, 2005
ORTHOPAEDIC COMPANY FINANCIALS: 1Q05 VS. 1Q04 Company/ Sales ($MM) vs. Prior AAP IMPLANTATE $3.81 +2% ARTHROCARE $38.82 +35% Sports Medicine $33.3 +44% Spine $5.4 +17% ARTIMPLANT $0.23 +10% CRYOLIFE2 $1.1 +255% ENCORE MEDICAL $75.4 +143% Surgical Implant $12.3 +14% Ortho Rehabilitatio...
BARE BONES® - May 15, 2005
AAP IMPLANTATE received a termination notice from ESSEX CHEMIE for a long-term supply agreement for Palacos bone cement, which aap distributes in Germany. aap feels the termination is invalid. The company posted 2004 Palacos sales of € 2.3MM (US $2.9MM). A cease in distribution could lead to b...
BARE BONES® - April 15, 2005
AAP IMPLANTATE signed a long-term production contract with an unnamed global orthopaedic company. The agreement is expected to begin affecting revenues in the 2nd half of 2005, with annual revenue for aap during the minimum 5-year-term of the contract to potentially exceed €2MM. (aap Implantate...
BARE BONES® - January 15, 2005
KEY STRATEGIC 510(K)S DECEMBER 2004 Aequos Knee Prosthesis (AAP IMPLANTATE) PLLA Cannulated Interference Screw (ADVANCED BIOMATERIALS) Parallax Acrylic Resin with Tracers (ARTHROCARE) BioPlus Calcium Sulfate (BERKELEY ADVANCED BIOMATERIALS) OSS/(Scarf) and OSW Screw (O.M.T. OBERFLAC...
BARE BONES® - July 15, 2004
ORTHOPAEDIC COMPANY FINANCIALS: AAP reports 1Q04 consolidated sales revenues of € 3.1MM (US $3.7MM), +4.5% from 1Q03. (aap Implantate, 6/11/04) AORTECH reported 2003 turnover of £ .36MM (US $.65MM), +390% from 2002. Earnings consist largely of upfront payments from licensees and purchases...
BARE BONES® - October 15, 2003
AAP IMPLANTATE received European approval for PerOssal® bone replacement material for use as a permanent filler or for bone defect reconstruction in traumatology, orthopaedic, dental, oral and maxillofacial surgery. PerOssal can be implanted into infected bone defects after surgical cleaning of t...
BARE BONES® - September 15, 2003
AAP IMPLANTATE reported 1H03 consolidated sales revenues of €6.1MM (US$ 6.7MM), down ~15% from the same period last year. The company anticipates a 2H03 recovery of business in Asia and further sales to arise from its reconstructed U.S. network. Before year-end, the company expects to launch it...
BARE BONES® - November 15, 2002
AAP IMPLANTATE completed an agreement with HJS GELENK-SYSTEM through which aap will handle manufacturing and marketing of the AEQUOS knee endoprosthesis system, while expanding its exclusive marketing rights to the system beyond Germany into other European countries, China and Japan. (aap Implantate...
BARE BONES® - October 15, 2002
AAP IMPLANTATE received clearance from FDA to market its Biorigid Nail Femur with CondyLock®, extending the applications of the company’s nail systems to the entire lower extremity. The company claims that its nail designs allow for different implantation techniques and new fixations using a...
BARE BONES® - July 15, 2002
AAP IMPLANTATE received a U.S. patent (09/672,322) for its Trauma Shoulder System (TSS). The patent applies to the unique fixing mechanism of the prosthesis to the shoulder muscles on the upper arm. The TSS secured a market share of roughly 10% in Germany alone. (aap Implantate AG , 6/6/02)
BARE BONES® - July 15, 2002
GESELLSCHAFT FÜR ELEKTRO-OSTEOTHERAPIE (GEOT) received CE Mark approval for its entire product range, which includes a magnetically-induced, invasive process to promote and accelerate bone healing. AAP, which will market the products, holds a 30% stake in GEOT and has until the end of 2003 to exe...
BARE BONES® - June 15, 2002
AAP IMPLANTATE received CE Mark approval for the HJS implant, a knee endoprosthesis that makes “almost natural movements possible” by means of a patented surface geometry. (aap Implantate AG, 5/13/02)
BARE BONES® - April 15, 2002
AAP IMPLANTATE’s subsidiary, CORIPHARM, received CE Mark approval for a granulate based on Cerabone bone ceramic. Cerabone granulate can be mixed with bone material to increase the available quantity of autogenous bone. OSARTIS, a company in which aap holds a 49% stake, received CE Mark approva...
BARE BONES® - January 15, 2002
AAP IMPLANTATE’s subsidiary, CORIPHARM MEDIZINPRODUKTE, will provide ESSEX CHEMIE with exclusive European rights for the sale of the EASYMIX® vacuum cementing system. (aap Implantate AG, 12/10/01)
ORTHOKNOW® - September 15, 2001
THE ORTHOPAEDIC INDUSTRY UNITES. John A. Engelhardt, Chief Executive Officer. Last Tuesday evening and into the wee hours of the morning, with total disregard for competitive instincts, the orthopaedic industry acted to be certain that adequate inventory of trauma and related products was available ...
BARE BONES® - August 15, 2001
AAP IMPLANTATE subsidiary, CORIPHARM, gained CE approval of its bone substitute material, Cerabone. (aap Implantate AG, 7/10/01)
BARE BONES® - December 15, 2000
AAP IMPLANTATE acquired 100% of CORIPHARM, MEBIO and CORIMED and a 49% stake in OSARTIS. The four companies, which together generated 1999 sales of DM 8.3MM ($3.6MM), are involved in research, development, manufacturing and marketing of endoprosthetic, bone substitute and wound healing products. (aa...
BARE BONES® - December 15, 2000
AAP IMPLANTATE received approval to market its entire range of products in China. Product shipments are scheduled for 4Q00 and will be handled by the company’s exclusive partner, P&T TECHNOLOGIES. (aap Implantate AG, 11/12/00)
BARE BONES® - December 15, 2000
ORTHOPAEDIC COMPANY FINANCIALS: (Company/Ticker Symbol: Sales ($MM): vs. Prior) ---9 MONTHS ENDING 9/30/00--- AAP $6.0(†) +75% (aap Implantate AG, 11/30/00) ARTIMPLANT $1.7(‡) +16% (Business Wire, 11/1/00) ---QUARTER ENDING 9/30/00--- BIONX $4.3 -12% Arrow sales stabilized at $2.8MM, ...
BARE BONES® - November 15, 2000
AAP IMPLANTATE acquired a 30% stake in GESELLSCHAFT FÜR ELEKTRO-OSTEO THERAPIE MBH (GEOT) and will assume marketing of GEOT’s products. Aap also obtained the option to acquire an additional 21% stake over the next 2 years. GEOT has developed a process for promoting and accelerating bone heal...
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2020 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group